GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.


PURPOSE Recurrent prostate cancer remains a major problem. Staging, grading and prostate specific antigen level at surgery are helpful but still imperfect predictors of recurrence. For this reason there is an imperative need for additional biomarkers that add to the prediction of currently used prognostic factors. MATERIALS AND METHODS We evaluated the… (More)
DOI: 10.1016/j.juro.2014.04.082


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics